Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human immune cells.

What are NGTs, how do they differ from GMOs and how are they agriculturally applied and regulated in the EU? View on euronews ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

In a new development, researchers have successfully created an efficient two-line system for hybrid seed production in ...

Learn more about whether Amarin Corporation plc or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether CRISPR Therapeutics AG or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

Recent IVG breakthroughs bring gene-edited human embryos closer, with CRISPR-Cas9 making heritable gene editing a reality ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.